Cohort study of causes of daytime sleepiness and sleepiness disorders
Part of Brain & nervous system, Mental health clinical trials.
This study follows people with frequent daytime sleepiness (sometimes from narcolepsy or hypersomnia) and compares them with matched healthy people, including some with sleep apnea. The goal is to better understand what causes sleepiness and to improve how these conditions are recognized and measured.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have frequent (daily or almost daily) daytime sleepiness or hypersomnia for at least 1 month
- You can have standard sleep/brain electrical testing (electrophysiological routine assessment) and agree to it
- You can provide informed consent
- If you are a healthy control, you will be age- and gender-matched (and may be a blood relative of a participant)
- If you have sleep apnea-related sleepiness, your obstructive sleep apnea must be untreated and severe, and you must meet specific sleep test results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people with narcolepsy or idiopathic hypersomnia have different patterns of daydreaming and mind-wandering compared to others with sleepiness but no clear diagnosis. It helps understand how certain brain states during sleep might affect waking thoughts.
This study tests a new medicine, HBS-301, for people with narcolepsy type 1 or type 2 who still have excessive daytime sleepiness. If you take other medications for sleepiness or mood, they must be stable for at least 3 months, and you cannot take some as-needed sleepiness medicines.
This study looks at how narcolepsy or idiopathic hypersomnia affects thinking and cardiovascular health, and how usual treatment medications may change those outcomes. It may help researchers understand risks and benefits of common hypersomnia therapies.
This study looks at how common sleep disorders affect children and teens. It may help us understand and treat conditions like poor sleep, tiredness during the day, and other sleep issues.
This study tests whether a new medication called samelisant can reduce extreme daytime sleepiness and sudden muscle weakness (cataplexy) in people with narcolepsy. If it works, it could offer a new treatment option for managing this sleep disorder.
This trial tests a new medication, HBS-301, in people with idiopathic hypersomnia (a condition causing excessive sleepiness without clear cause). It aims to see if the drug improves wakefulness and is safe.
Hear when a new Narcolepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.